HEADER HYDROLASE/INHIBITOR 26-MAY-22 8D0M TITLE HUMAN CD38 ECTODOMAIN BOUND TO A 78C-ADPR ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ECTODOMAIN; COMPND 5 SYNONYM: 2'-PHOSPHO-ADP-RIBOSYL CYCLASE,2'-PHOSPHO-ADP-RIBOSYL COMPND 6 CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE,2'-PHOSPHO-CYCLIC- COMPND 7 ADP-RIBOSE TRANSFERASE,ADP-RIBOSYL CYCLASE 1,ADPRC 1,CYCLIC ADP- COMPND 8 RIBOSE HYDROLASE 1,CADPR HYDROLASE 1,T10; COMPND 9 EC: 3.2.2.6,2.4.99.20; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NAD, HYDROLASE, AXON DEGENERATION, NEUROSCIENCE, HYDROLASE-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.BRATKOWSKI,W.GU REVDAT 3 25-OCT-23 8D0M 1 REMARK REVDAT 2 30-NOV-22 8D0M 1 JRNL REVDAT 1 21-SEP-22 8D0M 0 JRNL AUTH M.BRATKOWSKI,T.C.BURDETT,J.DANAO,X.WANG,P.MATHUR,W.GU, JRNL AUTH 2 J.A.BECKSTEAD,S.TALREJA,Y.S.YANG,G.DANKO,J.H.PARK,M.WALTON, JRNL AUTH 3 S.P.BROWN,C.M.TEGLEY,P.R.B.JOSEPH,C.H.REYNOLDS,S.SAMBASHIVAN JRNL TITL UNCOMPETITIVE, ADDUCT-FORMING SARM1 INHIBITORS ARE JRNL TITL 2 NEUROPROTECTIVE IN PRECLINICAL MODELS OF NERVE INJURY AND JRNL TITL 3 DISEASE. JRNL REF NEURON V. 110 3711 2022 JRNL REFN ISSN 0896-6273 JRNL PMID 36087583 JRNL DOI 10.1016/J.NEURON.2022.08.017 REMARK 2 REMARK 2 RESOLUTION. 2.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 21620 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.250 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.6300 - 4.9100 0.99 1504 154 0.1853 0.1697 REMARK 3 2 4.9100 - 3.9000 1.00 1446 147 0.1594 0.1762 REMARK 3 3 3.9000 - 3.4100 1.00 1422 145 0.1709 0.2269 REMARK 3 4 3.4100 - 3.1000 0.99 1427 145 0.2009 0.2595 REMARK 3 5 3.1000 - 2.8800 0.99 1374 140 0.2173 0.2638 REMARK 3 6 2.8700 - 2.7100 0.99 1417 145 0.2076 0.2301 REMARK 3 7 2.7100 - 2.5700 1.00 1391 141 0.2036 0.2623 REMARK 3 8 2.5700 - 2.4600 0.99 1385 142 0.1995 0.2216 REMARK 3 9 2.4600 - 2.3600 0.99 1383 141 0.2163 0.2951 REMARK 3 10 2.3600 - 2.2800 0.99 1384 141 0.2252 0.2716 REMARK 3 11 2.2800 - 2.2100 0.99 1377 140 0.2345 0.3143 REMARK 3 12 2.2100 - 2.1500 0.99 1382 140 0.2230 0.2687 REMARK 3 13 2.1500 - 2.0900 0.99 1360 140 0.2476 0.2581 REMARK 3 14 2.0900 - 2.0400 0.99 1368 139 0.2631 0.3005 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.206 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.864 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2039 REMARK 3 ANGLE : 0.851 2773 REMARK 3 CHIRALITY : 0.054 298 REMARK 3 PLANARITY : 0.006 345 REMARK 3 DIHEDRAL : 21.582 735 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8D0M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265419. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97741 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21620 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.040 REMARK 200 RESOLUTION RANGE LOW (A) : 46.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.25500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 8D0J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PH 5.5, 100 MM REMARK 280 AMMONIUM SULFATE, AND 15% POLYETHYLENE GLYCOL 3350, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.85600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.85600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 31.80600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.50900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 31.80600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.50900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.85600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 31.80600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 64.50900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.85600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 31.80600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 64.50900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 40.85600 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 521 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 246 REMARK 465 ARG A 247 REMARK 465 PHE A 284 REMARK 465 LEU A 285 REMARK 465 GLN A 286 REMARK 465 CYS A 287 REMARK 465 VAL A 288 REMARK 465 LYS A 289 REMARK 465 ASN A 290 REMARK 465 PRO A 291 REMARK 465 GLU A 292 REMARK 465 ASP A 293 REMARK 465 SER A 294 REMARK 465 SER A 295 REMARK 465 CYS A 296 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 GLY A 301 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 GLU A 304 REMARK 465 ASN A 305 REMARK 465 LEU A 306 REMARK 465 TYR A 307 REMARK 465 PHE A 308 REMARK 465 GLN A 309 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 280 CB CG CD NE CZ NH1 NH2 REMARK 470 ASP A 282 CG OD1 OD2 REMARK 470 LYS A 283 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 128 53.41 -143.24 REMARK 500 ARG A 140 -12.42 59.45 REMARK 500 ASN A 182 54.32 -95.01 REMARK 500 ASP A 202 -117.60 62.95 REMARK 500 VAL A 225 -51.21 -121.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8D0H RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0J RELATED DB: PDB REMARK 900 SAME PROTEIN, APO REMARK 900 RELATED ID: 8D0E RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0D RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0F RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0C RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0G RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0I RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND DBREF 8D0M A 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 8D0M ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 8D0M ALA A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 8D0M ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 8D0M ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 8D0M GLY A 301 UNP P28907 EXPRESSION TAG SEQADV 8D0M GLY A 302 UNP P28907 EXPRESSION TAG SEQADV 8D0M SER A 303 UNP P28907 EXPRESSION TAG SEQADV 8D0M GLU A 304 UNP P28907 EXPRESSION TAG SEQADV 8D0M ASN A 305 UNP P28907 EXPRESSION TAG SEQADV 8D0M LEU A 306 UNP P28907 EXPRESSION TAG SEQADV 8D0M TYR A 307 UNP P28907 EXPRESSION TAG SEQADV 8D0M PHE A 308 UNP P28907 EXPRESSION TAG SEQADV 8D0M GLN A 309 UNP P28907 EXPRESSION TAG SEQRES 1 A 265 ARG TRP ARG GLN GLN TRP SER GLY PRO GLY THR THR LYS SEQRES 2 A 265 ARG PHE PRO GLU THR VAL LEU ALA ARG CYS VAL LYS TYR SEQRES 3 A 265 THR GLU ILE HIS PRO GLU MET ARG HIS VAL ASP CYS GLN SEQRES 4 A 265 SER VAL TRP ASP ALA PHE LYS GLY ALA PHE ILE SER LYS SEQRES 5 A 265 HIS PRO CYS ASP ILE THR GLU GLU ASP TYR GLN PRO LEU SEQRES 6 A 265 MET LYS LEU GLY THR GLN THR VAL PRO CYS ASN LYS ILE SEQRES 7 A 265 LEU LEU TRP SER ARG ILE LYS ASP LEU ALA HIS GLN PHE SEQRES 8 A 265 THR GLN VAL GLN ARG ASP MET PHE THR LEU GLU ASP THR SEQRES 9 A 265 LEU LEU GLY TYR LEU ALA ASP ASP LEU THR TRP CYS GLY SEQRES 10 A 265 GLU PHE ALA THR SER LYS ILE ASN TYR GLN SER CYS PRO SEQRES 11 A 265 ASP TRP ARG LYS ASP CYS SER ASN ASN PRO VAL SER VAL SEQRES 12 A 265 PHE TRP LYS THR VAL SER ARG ARG PHE ALA GLU ALA ALA SEQRES 13 A 265 CYS ASP VAL VAL HIS VAL MET LEU ASP GLY SER ARG SER SEQRES 14 A 265 LYS ILE PHE ASP LYS ASP SER THR PHE GLY SER VAL GLU SEQRES 15 A 265 VAL HIS ASN LEU GLN PRO GLU LYS VAL GLN THR LEU GLU SEQRES 16 A 265 ALA TRP VAL ILE HIS GLY GLY ARG GLU ASP SER ARG ASP SEQRES 17 A 265 LEU CYS GLN ASP PRO THR ILE LYS GLU LEU GLU SER ILE SEQRES 18 A 265 ILE SER LYS ARG ASN ILE GLN PHE SER CYS LYS ASN ILE SEQRES 19 A 265 TYR ARG PRO ASP LYS PHE LEU GLN CYS VAL LYS ASN PRO SEQRES 20 A 265 GLU ASP SER SER CYS THR SER GLU ILE GLY GLY SER GLU SEQRES 21 A 265 ASN LEU TYR PHE GLN HET Q2C A 401 64 HETNAM Q2C [[(2~{R},3~{S},4~{R},5~{R})-5-(6-AMINOPURIN-9-YL)-3,4- HETNAM 2 Q2C BIS(OXIDANYL)OXOLAN-2-YL]METHOXY-OXIDANYL-PHOSPHORYL] HETNAM 3 Q2C [(2~{R},3~{S},4~{R},5~{R})-5-[5-[4-[[4-(2- HETNAM 4 Q2C METHOXYETHOXY)CYCLOHEXYL]AMINO]-1-METHYL-2- HETNAM 5 Q2C OXIDANYLIDENE-QUINOLIN-6-YL]-1,3-THIAZOL-3-YL]-3,4- HETNAM 6 Q2C BIS(OXIDANYL)OXOLAN-2-YL]METHYL HYDROGEN PHOSPHATE FORMUL 2 Q2C C37 H49 N8 O16 P2 S 1+ FORMUL 3 HOH *117(H2 O) HELIX 1 AA1 ARG A 58 HIS A 74 1 17 HELIX 2 AA2 PRO A 75 ARG A 78 5 4 HELIX 3 AA3 ASP A 81 ILE A 94 1 14 HELIX 4 AA4 THR A 102 ASP A 105 5 4 HELIX 5 AA5 TYR A 106 GLY A 113 1 8 HELIX 6 AA6 PRO A 118 LYS A 121 5 4 HELIX 7 AA7 ILE A 128 ARG A 140 1 13 HELIX 8 AA8 THR A 144 ASP A 147 5 4 HELIX 9 AA9 THR A 148 ASP A 155 1 8 HELIX 10 AB1 ASN A 183 ALA A 200 1 18 HELIX 11 AB2 SER A 220 VAL A 225 1 6 HELIX 12 AB3 GLU A 226 LEU A 230 5 5 HELIX 13 AB4 ASP A 252 GLN A 255 5 4 HELIX 14 AB5 ASP A 256 ARG A 269 1 14 SHEET 1 AA1 2 GLY A 52 PRO A 53 0 SHEET 2 AA1 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 AA2 4 LEU A 123 SER A 126 0 SHEET 2 AA2 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 AA2 4 VAL A 235 ILE A 243 1 O GLU A 239 N VAL A 204 SHEET 4 AA2 4 GLN A 272 ILE A 278 1 O ILE A 278 N VAL A 242 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.07 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.08 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.06 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.08 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.07 CRYST1 63.612 129.018 81.712 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015720 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007751 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012238 0.00000